Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
MENLO PARK, Calif., May 06, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve... | May 6, 2023
Source: marketscreener.com